This provider's $5.4M in total Medicare payments ranks in the 98th percentile of Dermatology providers nationally.
This provider's billing patterns fall within normal ranges for their specialty.
AI-generated analysis based on Medicare payment data.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $136.89 | $75.51 | 1.81x | $61.38 | $575.7K | 9.9K | 7.7K |
| 2015 | $131.88 | $72.65 | 1.82x | $59.23 | $567.8K | 9.2K | 7.3K |
| 2016 | $159.04 | $77.17 | 2.06x | $81.87 | $641.6K | 10.3K | 7.9K |
| 2017 | $155.21 | $67.75 | 2.29x | $87.46 | $557.0K | 9.7K | 7.6K |
| 2018 | $165.90 | $73.35 | 2.26x | $92.55 | $545.1K | 9.8K | 7.6K |
| 2019 | $185.32 | $78.95 | 2.35x | $106.37 | $546.3K | 9.9K | 7.7K |
| 2020 | $185.59 | $79.22 | 2.34x | $106.37 | $478.1K | 8.4K | 6.7K |
| 2021 | $171.99 | $74.13 | 2.32x | $97.86 | $511.0K | 8.4K | 6.6K |
| 2022 | $192.33 | $84.25 | 2.28x | $108.08 | $497.1K | 8.3K | 6.6K |
| 2023 | $186.56 | $81.51 | 2.29x | $105.05 | $477.1K | 8.1K | 6.4K |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| 17110 | Destruction of up to 14 skin growths | 22.2K | $1.8M | $79.69 | 1.99x |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | 24.7K | $1.3M | $51.40 | 2.05x |
| 17004 | Destruction of 15 or more skin growths | 9.6K | $1.1M | $111.51 | 1.98x |
| 17000 | Destruction of skin growth | 11.5K | $318.8K | $27.66 | 3.68x |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | 3.3K | $228.7K | $69.89 | 2.14x |
| 11100 | Biopsy of single growth of skin and/or tissue | 2.7K | $148.0K | $55.42 | 2.56x |
| 17262 | Destruction of malignant growth (1.1 to 2.0 centimeters) of trunk, arms, or legs | 1.1K | $130.4K | $122.48 | 2.10x |
| 11102 | Tangential biopsy of single skin lesion | 2.3K | $121.4K | $53.02 | 2.92x |
| 17282 | Destruction of malignant growth (1.1 to 2.0 centimeters) of face, ears, eyelids, nose, lips, or mouth | 526 | $79.1K | $150.43 | 1.94x |
| 17281 | Destruction of malignant growth (0.6 to 1.0 centimeters) of face, ears, eyelids, nose, lips, or mouth | 524 | $63.9K | $121.99 | 2.15x |
| 17003 | Destruction of 2-14 skin growths | 11.2K | $54.9K | $4.91 | 3.38x |
| 17272 | Destruction of malignant growth (1.1 to 2.0 centimeters) of scalp, neck, hands, feet, or genitals | 353 | $47.2K | $133.83 | 1.99x |
| 99202 | New patient office or other outpatient visit, typically 20 minutes | 503 | $23.7K | $47.06 | 1.84x |
| 11103 | Tangential biopsy of additional skin lesion | 468 | $18.9K | $40.39 | 2.10x |
| 17261 | Destruction of malignant growth (0.6 to 1.0 centimeters) of trunk, arms, or legs | 169 | $15.0K | $88.71 | 2.62x |
| 69100 | Biopsy of ear | 270 | $13.3K | $49.23 | 3.26x |
| 11101 | Biopsy of each additional growth of skin and/or tissue | 514 | $12.9K | $25.06 | 1.96x |
| 17271 | Destruction of malignant growth (0.6 to 1.0 centimeters) of scalp, neck, hands, feet, or genitals | 76 | $9.2K | $121.16 | 1.86x |
| 17263 | Destruction of malignant growth (2.1 to 3.0 centimeters) of trunk, arms, or legs | 29 | $3.9K | $134.53 | 1.81x |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | 119 | $3.6K | $30.20 | 2.00x |
This provider submits charges 2.17 times higher than what Medicare actually pays.
A markup ratio of 2.17x means for every $100 Medicare pays, this provider initially charges $217. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data